Article Details
Retrieved on: 2022-05-15 18:54:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's mRNA-based program in PCD uses ReCode's first-in-class Selective Organ Targeting (SORT) lipid nanoparticle (LNP) delivery platform, ...
Article found on: www.bakersfield.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here